American Public Health Association
EPANonrulemakingEPA-HQ-OPPT-2016-0735

HBCD (Hexabromocyclododecane) or Cyclic Aliphatic Bromide Cluster; TSCA Review and Risk Evaluation

RIN
Last modified
May 21, 2026
Comment window
closed 2903d ago
American Public Health Association filings
2

Activity

American Public Health Association filed 2 comments on this docket between Sep 21, 2017 and Aug 15, 2018. 24 other organizations filed here. The comment window closed 2903d ago.

What American Public Health Association filed (2)

Aug 15, 2018· Comment submitted by Georges C. Benjamin, MD, Executive Director, American Public Health Association (APHA)· EPA-HQ-OPPT-2016-0735-0081

Filed on regulations.gov — full text not in the inline record.

Sep 21, 2017· Comment submitted by Georges C. Benjamin, MD, Executive Director, American Public Health Association (APHA)· EPA-HQ-OPPT-2016-0735-0052

Filed on regulations.gov — full text not in the inline record.

Abstract

The EPA has prioritized chemicals for risk evaluation to address risks of injury to health and the environment, including HBCD (CASRNs 25637-98-4; 3194-55-6; and 3194-57-8). The EPA is requesting any information from the public on HBCD both domestically and internationally.

View on regulations.gov →